Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $418.08 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $79.16 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $56.62 | 2 | $0 (2023) |
| Eisai Inc. | $49.05 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $39.61 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $33.13 | 1 | $0 (2022) |
| TerSera Therapeutics LLC | $31.28 | 2 | $0 (2023) |
| SERVIER PHARMACEUTICALS LLC | $28.20 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $21.66 | 1 | $0 (2023) |
| Exelixis Inc. | $21.27 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $20.31 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $358.54 | 15 | AstraZeneca Pharmaceuticals LP ($56.62) |
| 2022 | $59.54 | 2 | Regeneron Healthcare Solutions, Inc. ($33.13) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Oncology | ||||||
| 05/04/2023 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI, MONJUVI | Food and Beverage | Cash or cash equivalent | $28.78 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 04/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Rare Disease | ||||||
| 04/06/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Oncology | ||||||
| 03/14/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $30.85 | General |
| Category: Oncology | ||||||
| 03/14/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 02/15/2023 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Hematology/Oncology | ||||||
| 02/09/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 02/07/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $37.95 | General |
| 02/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 02/01/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Oncology | ||||||
| 01/19/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $39.61 | General |
| 01/10/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 01/03/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/27/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $26.41 | General |
| Category: Hematology/Oncology | ||||||
| 12/21/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 64 | 87 | $43,371 | $8,788 |
| 2022 | 4 | 178 | 184 | $17,533 | $13,726 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 49 | $14,728 | $5,498 | 37.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 37 | 38 | $28,643 | $3,290 | 11.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $8,119 | $6,365 | 78.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 76 | 76 | $4,771 | $3,732 | 78.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 29 | $2,403 | $1,873 | 77.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 28 | 28 | $2,240 | $1,756 | 78.4% |
About Dana Marcom
Dana Marcom is a Gerontology healthcare provider based in Clarksville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2022. The National Provider Identifier (NPI) number assigned to this provider is 1861139131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dana Marcom has received a total of $418.08 in payments from pharmaceutical and medical device companies, with $358.54 received in 2023. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($418.08).
As a Medicare-enrolled provider, Marcom has provided services to 242 Medicare beneficiaries, totaling 271 services with total Medicare billing of $22,514. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Location Clarksville, TN
- Active Since 05/17/2022
- Last Updated 05/17/2022
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1861139131
Products in Payments
- JAKAFI (Drug) $50.38
- Lenvima (Drug) $49.05
- LIBTAYO (Biological) $33.13
- Zoladex (Drug) $31.28
- PEMAZYRE (Drug) $28.78
- Tibsovo (Drug) $28.20
- ULTOMIRIS (Biological) $21.66
- CABOMETYX (Drug) $21.27
- Nubeqa (Drug) $20.31
- ZEPZELCA (Drug) $19.30
- TAGRISSO (Drug) $18.67
- MONJUVI (Drug) $18.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.